Explore London's tech ecosystem
Quantum-computing startup applying quantum compression to shrink molecular-simulation algorithms and generate physics-informed datasets for AI training in drug discovery.
QUBIS is the commercialisation and technology transfer arm of Queen's University Belfast, founded in 1984 to turn academic research into high-impact commercial ventures. It takes equity stakes in university spin-outs across digital, engineering, environmental, life science, and scientific sectors, and manages a seed investment fund that provides early-stage capital of £50,000 to £150,000 per company. QUBIS has helped create over 100 technology spin-outs, generating more than £100 million in total capital raised.
Let your SOC team focus on real threats. Not alert firefighting.
Qi3 Ventures (formerly Qi3 Accelerator) is a Cambridge-based active angel investor group that combines cash funding with hands-on business development and technical expertise to help early-stage technology companies commercialise their products. The group invests primarily in Space, High Value Manufacturing, and e-commerce sectors, and co-invests alongside networks including Cambridge Angels and London Business Angels.
Get premium brands at low prices from a combined catalog of 500+ suppliers and distributors. Find 10k brands with guaranteed authenticity for EU & UK retail on Qogita.
Orchestration software that treats CPUs, GPUs and QPUs as a single logical machine, enabling seamless integration of quantum computers into classical high-performance computing environments.
All the essential Qt tools for all stages of Software Development Lifecycle: planning, design, development, testing, and deployment.
Qualcomm is a global semiconductor and wireless technology company best known for designing and supplying mobile chips, modems, and integrated circuits used in smartphones and connected devices. It is a leading licensor of 3G, 4G, and 5G wireless technology patents. The company also invests in AI and IoT applications through its Snapdragon platform.
Simulate customer and employee experiences before they happen, predict what comes next, and take intelligent action that drives better outcomes.
Quantcast | DSP Platform | DSP Programmatic Advertising
Manufacturer of next-generation superconducting quantum processors and components.
Decision intelligence platform using contextual AI and entity resolution to unify siloed data for fraud detection, AML, KYC and risk management across financial services and government. Achieved unicorn status in 2023 and centaur status (over $100m ARR) in 2024, with a $2.6 billion valuation.
Our trapped ion quantum computers and software solutions are the highest performing in the industry, enabling our users to solve industry's most complex problems.
Builds fault-tolerant quantum computers using silicon spin qubits fabricated on standard CMOS processes; delivered a full-stack silicon CMOS quantum computer to the UK National Quantum Computing Centre.
Clinical-stage engineered T-regulatory (Treg) cell therapy company targeting conditions driven by aberrant immune responses, including organ transplant rejection, Type 1 Diabetes and inflammatory bowel disease, with a strategic partnership with AstraZeneca.
Commercialising ULTRARAM, a compound-semiconductor non-volatile memory technology using quantum resonant tunnelling, targeting AI, compute-in-memory and neuromorphic computing applications.
Quint Group is a bootstrapped fintech growth platform headquartered in Cheshire, England, focused on building and scaling the next generation of businesses in credit and payments. Founded in 2009, the group owns and operates several fintech brands including Monevo, Credit Technologies, Acquired, and Infinian, and has generated over £500 million in revenues without raising external equity. Quint serves more than 450 banks, lenders, and fintechs across the UK, US, and Australia.
Save time, reduce costs and enjoy work with Quinyx, the cloud-based, mobile-first AI-powered Workforce Management Platform.
The Enterprise Hub at the Royal Academy of Engineering, launched in April 2013, is the UK's top-ranked startup hub supporting engineering and deep-tech entrepreneurs through grants (over £19 million awarded), mentoring from Academy Fellows, and programmes including Enterprise Fellowships, the Shott Scale Up Accelerator, Leaders in Innovation Fellowships, and Regional Talent Engines. It has supported over 600 entrepreneurs who have collectively raised £3.8 billion and created more than 6,100 jobs, with regional hubs also operating in Liverpool, Newcastle, Wales, and Northern Ireland.
RAW Venture Partners is an Edinburgh-based boutique angel investment group and family office vehicle founded in 2014. The firm assists IT entrepreneurs and early-stage businesses in gaining access to working capital, providing mentoring and angel or follow-on investment in companies across the UK, Europe, and the US. It has invested over $10 million in businesses worldwide.
RBS Equity Finance was an investment division of the Royal Bank of Scotland Group, formed in 2002, that consolidated several of the bank's equity and private equity operations including Royal Bank Private Equity, Royal Bank Development Capital, Royal Bank Ventures, and Property Ventures. The division provided direct equity investment to businesses and is no longer operating as a distinct entity following subsequent restructuring of the RBS Group.
The Regulatory Innovation Office (RIO) is a UK government office within the Department for Science, Innovation and Technology, established in October 2024. It works to update regulation and speed up approval times for emerging technologies, helping regulators across government to work together effectively so that innovative products and services can reach the market faster.
ROA Ventures Ltd is a Glasgow-based company incorporated in 2018 that developed an e-commerce platform for influencer marketing, connecting brands, customers, and marketers. The company also launched KITVENDR, an online sports merchandising platform for community and semi-professional sports clubs. The company has an active proposal to strike off at Companies House.
RQ Bio develops long-acting monoclonal antibodies for seasonal influenza, offering immediate, potent, and lasting protection against severe disease.